Antithrombotics and cancer: evidence for survival benefit.
Kakkar
Ajay K
AK
Hammersmith Hospital - Imperial College, Thrombosis Research Institute, London, UK. akkakkar@tri-london.ac.uk
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D016896:Treatment Outcome
D005343:Fibrinolytic Agents